Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV000348087 | SCV000478593 | uncertain significance | Ehlers-Danlos syndrome type 7A | 2016-06-14 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV000755975 | SCV000569098 | uncertain significance | not provided | 2019-12-18 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
| ARUP Laboratories, |
RCV000755975 | SCV000883664 | uncertain significance | not provided | 2017-12-20 | criteria provided, single submitter | clinical testing | |
| Illumina Laboratory Services, |
RCV001168153 | SCV001330724 | likely benign | Ehlers-Danlos syndrome, classic type | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
| Labcorp Genetics |
RCV002230727 | SCV001496998 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2023-08-30 | criteria provided, single submitter | clinical testing |